Management of Iron deficiency syndromes and their correction with nutritional drugs

In the literature there is little information about the occurrence of dielectrolytes with inadequately selected parenteral-enteral correction. This fully applies to the correction of iron deficiency in colorectal cancer (CRC). Material and methods. On examination were 51 patients with CRC (T3N1M0 and T4N0M1) and iron deficiency of various severity. Nutritional status was assessed by the parameters of a known alimentary-volemic diagnosis (AED). Iron deficiencies resulting from chronic blood loss were assessed by the content of serum iron, ferritin, transferrin, the level of Hb and Ht, the number and average volume of red blood cells, and the average content of Hb in the red blood cell. The control group consisted of 10 patients with iron-deficient anemia. Results. One of the components of the AVD is the determination of electrolyte deficiencies, including gland. With a deficit of free iron in plasma up to 11%, a decrease in hemoglobin level and Ht, a slight decrease in the number of erythrocytes and normal parameters of ferritin, the average volume of erythrocyte and the content of Hb in it were sufficient nutritive correction mixtures containing 3.0-3.5 mg of iron in 100 g dry product. With a higher iron deficiency, additional parenteral administration of its drugs was required: as part of the nutritional correction, as a pharmacological supplement, supplements were injected with non-sorbed or sorbed iron on a special matrix (ironMatrix), which guaranteed the stability of the iron complex and its controlled release in the body. At the same time, sorbed iron provided a higher safety (no complications were observed in any of the studies. with the administration of non-sorbed iron in 2 cases, there were unpleasant sensations in the heart area, in the right hypochondrium, resembling signs of iron overload (ferritin could increase to 1340 mg), stopped, however, only by the administration of a hepatoprotector and 0.9% of the sodium chloride solution without the additional use of an antidote. Conclusion. For the sake of safety of iron deficiency correction (prevention of toxic-metabolic complications) when conducting a comprehensive nutritional correction in patients with CRC complicated by mild chronic anemia with iron deficiency not more than 11%, it is advisable to use drugs containing iron (3-3.5 mg per 100 g of dry product), and in case of a pronounced shortage of it, supplement the nutritional support with parenteral preparations of sorbed iron under the control of the parameters of iron metabolism.